Can a brain tumour be removed completely? — it depends on the type and where it sits

Some tumours have a clear border and push healthy brain aside rather than growing into it. Many meningiomas, pituitary tumours, acoustic neuromas and single metastases fall into this group, and they can often be removed completely (a "gross total resection"). Other tumours — most importantly the diffuse gliomas (including astrocytomas and glioblastoma) — grow into normal brain like ink spreading through paper. Their true edge cannot be seen, so even a removal that looks complete on the MRI can leave microscopic cells behind. This is the single biggest reason a tumour cannot always be taken out entirely.

The brain has regions that control speech, movement, vision and memory — surgeons call these "eloquent" areas. A tumour sitting in or right beside one of them limits how much can safely be removed, because taking the last piece could cause permanent weakness, speech loss or blindness. A tumour of exactly the same type in a "silent" part of the brain may be fully removable. For eloquent tumours, techniques such as awake brain mapping — coordinated with our neurosurgical partners — let the team remove more while checking your speech and movement in real time.

Age, general fitness and other medical conditions affect how much surgery your body can safely tolerate. A tumour wrapped around major blood vessels, crossing into both halves of the brain, or present as several separate lesions may not be safely removable in full. In these situations the plan shifts toward relieving pressure, getting tissue for molecular testing, and controlling the tumour with radiation and medical therapy. When surgery is judged too risky altogether, the tumour may be called inoperable — but that does not mean it cannot be treated.

Sometimes, yes — and sometimes only partly. Whether a brain tumour can be fully removed depends on where it sits, its type, and how sharply it is separated from healthy brain. Well-defined tumours like many meningiomas or a single metastasis can often be removed in one piece (a "gross total resection"). Diffuse gliomas send finger-like tendrils into normal brain, so a surgeon may remove all the tumour that is safely reachable while protecting speech, movement and vision. All surgery at CION is delivered through accredited neurosurgical partners; our team then plans the radiation and medical therapy that follows.

Gross total resection (GTR) means the surgeon removed all of the tumour that could be seen on the MRI and during surgery — with no obvious tumour left behind on the follow-up scan. It is the goal for many well-defined tumours. However, "no tumour visible on MRI" is not the same as "no cell left anywhere". With infiltrating tumours, microscopic cells can remain even after a complete-looking removal, which is why radiation or medical therapy often follows surgery. Your surgeon and neuro-oncologist will explain what the scan and pathology show for your specific tumour.

Removing more tumour usually helps, but not at any cost. The guiding principle in modern neuro-oncology is maximal safe resection — take out as much as possible while protecting the parts of the brain that control speech, movement, memory and vision. Pushing to remove the last sliver near a critical area can cause permanent disability that outweighs the benefit. For tumours in these "eloquent" regions, techniques like awake mapping — coordinated with our neurosurgical partners — help remove more, safely.

A partial removal (debulking) is still valuable. Reducing the tumour bulk can relieve pressure, ease symptoms, provide tissue for molecular testing, and make follow-up radiation and medical therapy more effective. If a tumour is judged unsafe to operate on at all, it may be called inoperable — but "inoperable" does not mean "untreatable". Radiation therapy (including focused radiosurgery for suitable tumours), medical therapy, and steroid and seizure control can still control the tumour and protect quality of life. CION delivers these directly.

It can. Even after a scan shows no remaining tumour, some types can recur — especially infiltrating gliomas, higher-grade tumours, and any tumour where microscopic cells were left in healthy-looking brain. That is why follow-up MRI scans are scheduled at set intervals, and why radiation or medical therapy is often recommended after surgery for higher-grade tumours. Benign, fully-removed tumours have a much lower chance of returning. Your neuro-oncology team will set a monitoring plan matched to your tumour type and grade.

CION coordinates brain tumour surgery with accredited neurosurgical partners — we do not operate in-house. What CION delivers directly is the rest of the journey: expert imaging and diagnosis, molecular testing (IDH, MGMT, 1p/19q), radiation therapy (IMRT/IGRT), medical and systemic therapy, steroid and seizure management, and supportive and rehabilitation care. Every patient is discussed by a tumour board, so your surgery, radiation and medicines are planned as one connected treatment — not in silos. Consultations run 45 minutes so your questions are fully answered.